Ken Griffin Immuno Precise Antibodies Ltd. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$0.98 - $1.53 $2,156 - $3,366	-2,200 Reduced 13.5%	14,100 $14,000
Q1 2024 May 15, 2024	SELL	$1.4 - $2.41 $273,840 - $471,396	-195,600 Reduced 92.31%	16,300 $24,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.3 $2,886 - $5,979	2,600 Added 1.24%	211,900 $362,000
Q3 2023 Nov 14, 2023	SELL	$1.76 - $3.04 $14,960 - $25,840	-8,500 Reduced 3.9%	209,300 $383,000
Q2 2023 Aug 14, 2023	SELL	$2.42 - $4.04 $8,228 - $13,736	-3,400 Reduced 1.54%	217,800 $644,000
Q1 2023 May 15, 2023	SELL	$2.77 - $5.49 $122,157 - $242,109	-44,100 Reduced 16.62%	221,200 $612,000
Q4 2022 Feb 14, 2023	BUY	$4.5 - $5.72 $9,000 - $11,440	2,000 Added 0.76%	265,300 $1.38 Million
Q3 2022 Nov 14, 2022	SELL	$3.77 - $6.39 $260,507 - $441,549	-69,100 Reduced 20.79%	263,300 $1.05 Million

1.9M

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $8.44M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.